NYXH — Nyxoah SA
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1857190 ·
Belgium
Last close
$0.90
Market Cap
$91.65M
52W High
$5.39
52W Low
$0.80
ADV30
218,325
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 9,170,000 | 5,785,000 | -21,852,000 | -17,830,000 | 148,725,000 | 15,430,000 | 80,765,000 |
| Jun 2026 | 7,675,000 | 4,584,000 | -20,548,000 | -32,964,000 | 168,466,000 | 64,115,000 | 85,357,000 |
| Mar 2026 | 6,372,000 | 3,638,000 | -20,503,000 | -15,944,000 | 97,598,000 | 12,934,000 | 61,727,000 |
| Dec 2025 | 5,644,000 | 3,625,000 | -18,259,000 | -23,513,000 | 118,471,000 | 30,001,000 | 69,342,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-71,855,000
Investing CF
$-16,154,000
Financing CF
$128,292,000
CapEx
$-3,621,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.16
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-353,570,000
Inventory
$3,706,000
Receivables
$9,953,000
ST Investments
$33,670,000
EBIT TTM
$-83,376,000
Pretax Income TTM
$-94,529,000
Interest Exp TTM
$11,153,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$21,663,000
EBITDA
$-82,744,000
Free Cash Flow
$-46,059,124
Enterprise Value
$116,315,136
Total Cash
$97,785,000
Total Debt
$59,988,000
Shares Out
101,840,217
Trailing EPS
$-2.55
Book Value
$0.97
ROE
-122.7%
ROA
-36.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,020,000 | -82,942,000 | -90,085,000 | 118,471,000 | 69,342,000 | 49,129,000 | -68,979,000 |
| Dec 2024 | 4,521,000 | -58,809,000 | -59,236,000 | 158,406,000 | 45,152,000 | 113,254,000 | -49,226,000 |
| Dec 2023 | 4,348,000 | -45,102,000 | -43,212,000 | 124,157,000 | 26,135,000 | 98,022,000 | -44,778,000 |
| Dec 2022 | 3,084,000 | -32,499,000 | -31,225,000 | 146,071,000 | 25,747,000 | 120,324,000 | -28,756,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.85
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SKIN | SkinHealth Systems Inc. | $90.40M | $13.88 | — |
| VANI | Vivani Medical, Inc. | $94.71M | $1.05 | — |
| STXS | Stereotaxis, Inc. | $88.39M | $0.88 | — |
| STIM | Neuronetics, Inc. | $99.49M | $1.28 | — |
| LAKE | LAKELAND INDUSTRIES INC | $82.33M | $8.29 | — |
News headlines (Yahoo Finance, 1h cache)
Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case
2026-11-18 07:00 · Yahoo
Nyxoah (NYXH) Q3 2026 Earnings Call Transcript
2026-11-06 17:03 · Yahoo
Nyxoah S.A. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Nyxoah SA (NYXH) Q3 2026 Earnings Call Highlights: U.S. ...
2026-11-06 05:26 · Yahoo
Nyxoah SA (NYXH) Reports Q3 Loss, Lags Revenue Estimates
2026-11-06 00:00 · Yahoo
Nyxoah Reports Third Quarter 2026 Financial and Operating Results
2026-11-05 21:05 · Yahoo
Nyxoah (ENXTBR:NYXH) Stock Sees Fair Value Falls After Q2 Analyst Target Cuts
2026-10-22 10:11 · Yahoo
Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom Fisher
2026-10-20 12:55 · Yahoo
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
2026-10-19 12:00 · Yahoo
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
2026-10-15 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.